HTMwire
Datrend Systems logo

Datrend Systems

Patient Simulators

HTMwire assessment

Biomedical test equipment manufacturer specializing in patient simulators, SpO2 performance testers, and infusion device analyzers for biomed PM workflows.

Key Features

  • vPad patient simulators
  • SpO2 performance testing tools
  • Infusion device analyzer (IDA)
  • Electrical safety analyzers
  • Automated test documentation

What It Helps You Do

Integrated multi-test platform Infusion device testing SpO2 verification Automated PM documentation

What Sets Them Apart

Strong in SpO2 and infusion device testing — vPad platform integrates multiple test modalities into a single portable device for efficient PM workflows.

How Datrend Systems Uses AI

No AI/ML

HTMwire's independent read on the technology — not the vendor's marketing claim.

Key Numbers

  • Operating since 1991
  • Infutest 2000 patented in the late 1980s

Tags

patient-simulators spo2-testers infusion-pump-analyzers calibration

Frequently Asked Questions

What does Datrend Systems make?

Datrend Systems develops and manufactures biomedical test instruments including the vPad patient simulators and electrical safety analyzers, the Infutest infusion device analyzer, and SpO2 performance testing tools, with automated test documentation for PM workflows.

Where is Datrend Systems based and how long has it operated?

Datrend is a Canadian-owned company based in Richmond, British Columbia, operating since its 1991 launch. It developed and patented its first product, the Infutest 2000 infusion pump tester, in the late 1980s.

Who owns Datrend Systems?

Datrend describes itself as a Canadian-owned company. No parent company or external investor is publicly disclosed, and individual founder names are not published, though its leadership and founders have biomedical engineering backgrounds.

Sources

  1. Datrend company profile (Canadian-owned, since 1991)
  2. TechNation showcase: Datrend and the Infutest 2000

We cite a primary or named source for every claim on this page. How we evaluate →

Last updated: June 9, 2026